# KDM2A — selective Th2-suppressor mechanism dossier **Screen signal:** Th2-arm z = -2.22, magnitude-controlled residual = -1.72, condition = Stim48hr, class = TF **Final verdict (post–adversarial review):** LIKELY_ARTIFACT · investigator: likely_artifact (medium conf) · citations: supported ## Hypothesis Because KDM2A is tightly coupled to PI3K/mTOR/SGK1-driven rRNA transcription, ribosome biogenesis and proliferation, its knockdown most likely dampens the highly proliferation/autocrine-amplified Th2 program more than the low-baseline Th1 program in a Th2-polarizing assay, rather than acting as a bona fide selective GATA3/IL4 regulator. ## Mechanism There is no primary literature linking KDM2A to GATA3, IL4, or Th2 differentiation, and its known biochemistry predicts the OPPOSITE of a Th2 activator: KDM2A is an H3K36me1/2 eraser that binds unmethylated CpG islands and REPRESSES transcription, it negatively regulates NF-kB (demethylates p65) and promotes proteasomal degradation of TCF/LEF (Wnt). Losing KDM2A would raise H3K36me2 at cis-regulatory elements (opposing NSD1/2 that support enhancer H3K27ac), increase NF-kB, and stabilize TCF1/LEF1 (a pro-GATA3/pro-Th2 factor) — each of which predicts UNCHANGED or INCREASED Th2, not a decrease. The only route consistent with reduced Th2 upon KD is indirect: KDM2A is an essential gene (embryonic-lethal KO) governing PI3K/mTOR/SGK1-controlled rDNA transcription and ribosome biogenesis, so KD lowers proliferative/biosynthetic capacity and preferentially collapses the STAT6→GATA3→IL4 autocrine amplification loop while leaving a flat Th1 baseline flat. That is a global-dampening mechanism, not selective Th2 regulation. **Bypasses T-bet / Th1?** True — None of KDM2A's known activities induce T-bet/Th1: loss increases NF-kB, Wnt/TCF-LEF, and H3K36me2, and impairs proliferation — so the Th1-flat readout is not driven by Th1 induction. However, the flatness is better explained by a low Th1 baseline plus generic dampening than by a genuine Th2-specific circuit, so bypassing T-bet here is not evidence of a real selective suppressor. ## Evidence - KDM2A/FBXL11 is an H3K36me1/2 demethylase that binds unmethylated CpG islands and acts as a transcriptional REPRESSOR, predicting the opposite of a Th2 activator. _source:_ KDM2A - Wikipedia; EMBO J 2010 (KDM2A regulator of rRNA transcription), https://en.wikipedia.org/wiki/KDM2A - KDM2A is a negative regulator of NF-kB (demethylates p65) and its loss enhances inflammatory NF-kB signaling — loss would not lower an inflammatory/Th program. _source:_ Reviews of FBXL11/KDM2A NF-kB regulation (liver-specific Kdm2a deficiency enhances NF-kB), summarized via KDM2A literature - KDM2A promotes proteasomal degradation of TCF/LEF; since TCF1/LEF1 promote GATA3 and Th2, losing KDM2A should raise, not lower, the Th2 program. _source:_ Lysine Demethylase KDM2A Promotes Proteasomal Degradation of TCF/LEF, PMC10670284, https://pmc.ncbi.nlm.nih.gov/articles/PMC10670284/ - KDM2A is essential (embryonic-lethal KO, represses cell-cycle regulators) and controls rDNA/rRNA transcription and ribosome biogenesis downstream of PI3K/mTOR/SGK1 — a proliferation/growth axis prone to global-dampening screen artifacts. _source:_ Fbxl11/Kdm2a essential in embryonic development (PubMed 25463925); KDM2A regulator of rRNA transcription (EMBO J 2010, doi:10.1038/emboj.2010.56); SF-KDM2A rDNA/proliferation (PubMed 28350064) - H3K36me2 deposited by NSD enzymes activates cis-regulatory elements (H3K27ac); KDM2A erases H3K36me2, so its loss would increase enhancer activity — opposite of suppressing Th2 genes. _source:_ Systematic perturbations of SETD2/NSD1/2/3/ASH1L on H3K36 methylation, bioRxiv 2023.09.27.559313 ## Proposed confirming experiment Perform arrayed CRISPRi KD of KDM2A (plus a magnitude-matched non-Th2 essential control and a scramble) in primary human CD4+ T cells under parallel Th2-polarizing and Th1-polarizing conditions at 48hr stim. Read out (a) Th2 (GATA3, IL4/IL5/IL13 by intracellular flow + qPCR) vs Th1 (T-bet, IFNG) as the selectivity test, AND critically (b) global-dampening covariates on the SAME cells: CellTrace proliferation (division index), viability, cell size (FSC), and bulk translation by O-propargyl-puromycin (OPP) incorporation, plus rRNA/45S pre-rRNA levels. Genuine selective suppression requires Th2 loss that persists after regressing out proliferation/OPP/viability and is NOT reproduced by the magnitude-matched control. Add two orthogonal checks: (i) rescue with catalytically-dead (JmjC-mutant) vs WT KDM2A to test whether the phenotype is demethylase-dependent, and (ii) CUT&RUN for H3K36me2 at the GATA3/Th2 LCR/IL4 locus to confirm direction — if KD raises H3K36me2 yet Th2 falls, the effect is indirect/global rather than a direct chromatin mechanism. ## Adversarial review - **Citations check:** supported - **Agrees artifact call (True):** True - **Notes:** All five citations are real and support their claims: KDM2A/FBXL11 is a CpG-island-binding H3K36me1/2 demethylase and repressor (EMBO J 2010, PMC2876952; NAR 2019); rRNA/ribosome-biogenesis regulator; embryonic-lethal essential gene repressing cell-cycle regulators (PubMed 25463925); NF-kB p65 negative regulator; and SCF/neddylation-dependent degrader of TCF/LEF (PMC10670284). The internal logic is coherent and cuts against a bona fide direct Th2 activator: as a repressor of NF-kB and a degrader of TCF1/LEF1 (pro-GATA3), KDM2A loss should if anything DE-repress/raise the Th2 program, so a KD-reduces-Th2 screen hit is hard to reconcile with direct GATA3/IL4 activation and is better explained by loss of an essential proliferation/rRNA/ribosome-biogenesis gene. Two caveats weaken confidence but do not overturn the artifact call: (1) NAR 2019 shows KDM2A's demethylase activity is largely dispensable and KDM2B is the dominant repressor, so the repressor framing is overstated; (2) essential/ribosome-biogenesis dampening predicts NON-selective loss of both Th1 and Th2 — the assertion that Th2 is uniquely more proliferative/autocrine-amplified than the equally proliferative Th1 effector program is unsupported hand-waving and is the strongest objection to a clean proliferation-artifact story. Critically, ALL cited mechanism is from non-T-cell systems (HEK293T, breast/gastric cancer, embryo, liver); there is zero direct CD4 T-cell evidence for a GATA3/IL4 role. Net: no support for a bona fide selective Th2 regulator; essentiality + wrong-direction repressor biology make likely_artifact the best-supported call.